State Street’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$771K Sell
849,522
-1,800,664
-68% -$1.63M ﹤0.01% 3542
2025
Q1
$1.2M Sell
2,650,186
-24,326
-0.9% -$11K ﹤0.01% 3391
2024
Q4
$1.34M Buy
2,674,512
+66,160
+3% +$33.2K ﹤0.01% 3422
2024
Q3
$2.36M Buy
2,608,352
+45,483
+2% +$41.2K ﹤0.01% 3274
2024
Q2
$2.56M Buy
2,562,869
+385,660
+18% +$385K ﹤0.01% 3220
2024
Q1
$3.22M Buy
2,177,209
+80,600
+4% +$119K ﹤0.01% 3113
2023
Q4
$2.29M Buy
2,096,609
+73,763
+4% +$80.4K ﹤0.01% 3270
2023
Q3
$2.39M Buy
2,022,846
+84,134
+4% +$99.3K ﹤0.01% 3255
2023
Q2
$2.73M Buy
1,938,712
+1,501,216
+343% +$2.12M ﹤0.01% 3268
2023
Q1
$656K Hold
437,496
﹤0.01% 3656
2022
Q4
$512K Sell
437,496
-2,600
-0.6% -$3.04K ﹤0.01% 3764
2022
Q3
$497K Hold
440,096
﹤0.01% 3781
2022
Q2
$695K Sell
440,096
-1,665,011
-79% -$2.63M ﹤0.01% 3717
2022
Q1
$3.24M Buy
2,105,107
+30,873
+1% +$47.5K ﹤0.01% 3380
2021
Q4
$5.08M Sell
2,074,234
-3,384,217
-62% -$8.29M ﹤0.01% 3235
2021
Q3
$13.8M Buy
5,458,451
+3,590,405
+192% +$9.05M ﹤0.01% 2696
2021
Q2
$5.32M Buy
1,868,046
+1,802,392
+2,745% +$5.14M ﹤0.01% 3216
2021
Q1
$154K Buy
65,654
+7,500
+13% +$17.6K ﹤0.01% 3868
2020
Q4
$102K Hold
58,154
﹤0.01% 3806
2020
Q3
$54K Hold
58,154
﹤0.01% 3749
2020
Q2
$51K Sell
58,154
-1,695,837
-97% -$1.49M ﹤0.01% 3705
2020
Q1
$1.45M Sell
1,753,991
-43,932
-2% -$36.4K ﹤0.01% 3193
2019
Q4
$1.6M Buy
1,797,923
+24,016
+1% +$21.4K ﹤0.01% 3313
2019
Q3
$1.74M Buy
1,773,907
+116,264
+7% +$114K ﹤0.01% 3262
2019
Q2
$1.82M Sell
1,657,643
-255,599
-13% -$281K ﹤0.01% 3275
2019
Q1
$2.51M Sell
1,913,242
-403,097
-17% -$528K ﹤0.01% 3061
2018
Q4
$2.12M Sell
2,316,339
-332,649
-13% -$304K ﹤0.01% 3100
2018
Q3
$5.44M Buy
2,648,988
+101,961
+4% +$209K ﹤0.01% 2826
2018
Q2
$4.59M Buy
2,547,027
+206,905
+9% +$373K ﹤0.01% 2904
2018
Q1
$5.51M Buy
2,340,122
+747,980
+47% +$1.76M ﹤0.01% 2753
2017
Q4
$2.99M Buy
1,592,142
+37,959
+2% +$71.4K ﹤0.01% 3025
2017
Q3
$3.86M Buy
1,554,183
+16,415
+1% +$40.8K ﹤0.01% 2916
2017
Q2
$4.24M Buy
1,537,768
+143,827
+10% +$396K ﹤0.01% 2816
2017
Q1
$4.21M Buy
1,393,941
+198,562
+17% +$599K ﹤0.01% 2787
2016
Q4
$3.78M Buy
1,195,379
+101,943
+9% +$322K ﹤0.01% 2833
2016
Q3
$3.73M Buy
1,093,436
+80,381
+8% +$274K ﹤0.01% 2727
2016
Q2
$2.31M Buy
1,013,055
+113,031
+13% +$258K ﹤0.01% 2972
2016
Q1
$2.26M Sell
900,024
-22,506
-2% -$56.5K ﹤0.01% 2955
2015
Q4
$3.05M Buy
922,530
+78,195
+9% +$259K ﹤0.01% 2809
2015
Q3
$2.04M Sell
844,335
-13,141
-2% -$31.8K ﹤0.01% 2995
2015
Q2
$2.51M Buy
857,476
+52,523
+7% +$154K ﹤0.01% 2976
2015
Q1
$3.22M Buy
804,953
+63,210
+9% +$253K ﹤0.01% 2811
2014
Q4
$2.23M Buy
741,743
+36,952
+5% +$111K ﹤0.01% 2996
2014
Q3
$1.79M Buy
704,791
+75,139
+12% +$190K ﹤0.01% 3065
2014
Q2
$1.55M Buy
629,652
+1,873
+0.3% +$4.61K ﹤0.01% 3148
2014
Q1
$1.67M Buy
627,779
+17,957
+3% +$47.7K ﹤0.01% 3129
2013
Q4
$1.77M Buy
609,822
+638
+0.1% +$1.86K ﹤0.01% 3117
2013
Q3
$1.87M Buy
609,184
+38,071
+7% +$117K ﹤0.01% 3076
2013
Q2
$1.83M Buy
+571,113
New +$1.83M ﹤0.01% 3024